All News

New PSMA PET/CT can detect signs of prostate cancer within elderly patients without the need of a biopsy.

Patients with nonmetastatic node-positive bladder cancer may have similar survival rates whether they underwent treatment with surgery or radical dose radiotherapy.

I only allow anxiety to take up 15 minutes of my days.

Reporting MPN side effects to the care team, regardless of how “little” they may seem, can help determine how to adjust treatment to address these symptoms, an expert said.

Treatment with Welireg significantly improved progression-free survival rates in patients with advanced renal cell carcinoma, the most common type of kidney cancer.

Patients with prostate cancer may have an inherited or acquired BRCA mutation, and both can have treatment implications, an expert said.

Patients with primary central nervous system lymphoma aged 70 and older may be eligible for Imbruvica as maintenance treatment.

Adults with cancer can benefit from mindfulness-based interventions and other therapies to manage symptoms of anxiety and depression.

Beginning in the long, cold winter of 2022, I began a series of hospitalizations to treat my stage 2 non-specific non-Hodgkin Lymphoma. For the next six months, I would spend a week in the hospital every single month.

Cancer teams can decode and analyze DNA from a patient’s tumor to diagnose the disease, determine personalized treatment plans and assess the response to treatment.

The knowledge of DNA mutations continues to shape the way that breast cancer is treated.

In patients with cancer, psychological distresses such as anxiety and depression are associated with slower time from receiving a diagnosis until the first session of treatment.

Prehabilitation can help patients become eligible for certain cancer treatments, or also help them recover from therapies, while also improving their overall health and fitness, an expert explained.

I am a big believer in the proverbial toolbox.

As with many other areas in health care, some patients may face barriers when it comes to genetic services for breast cancer.

Researchers are using artificial intelligence to diagnose sarcopenia in patients with head and neck cancer.

After being diagnosed with cancer, I set intentions — both spiritual and practical — that helped guide me through the experience.

I had acute myeloid leukemia in 2016 and tackled it with chemo. I had a recurrence in 2020 and tackled it with chemo and a bone marrow transplant.

Men with prostate cancer who participated in group-based resistance and aerobic exercise regimens had improved sexual function compared with those who underwent usual care.

From Eric Braeden announces that he is cancer free to Tom Jones dying from cancer, this is what’s happening in the oncology space this week.

An expert discusses the impact on patients and families lacking equal access to counseling and testing.

Researchers have found that interventions can make breast cancer survivors nearly 1.5 times more likely to continue with important post-surgical hormonal therapy.

Patients with blood cancers who had limited social support tended to have poorer survival and a higher likeliness to be hospitalized, recent research showed.

Over the years, I have found social media to be a powerful tool for connecting people with Lynch syndrome.

Although the pandemic prevented Branwyn Lee's family from being with her during cancer treatment, she never felt alone on her journey.

The Food and Drug Administration granted a priority review to Tibsovo for the treatment of patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome.

With multiple therapies available for patients with myeloma, there are some considerations that patients should discuss with their clinicians before choosing which one is right for them, an expert said.

Recent results highlight that men with the disease have not lived as long as female patients have during the past three decades.

The day before I was diagnosed with prostate cancer, I didn’t pay enough attention to my brother-in-law’s arduous journey with Parkinson’s disease.

Patients with HER2-positive metastatic breast cancer may receive sufficient first-line treatment with Perjeta plus Herceptin without chemotherapy.